## Background: Kaposi's sarcoma-associated herpesvirus (kshv) dna sequences have been identified in approximately 95% of kaposi's sarcoma (ks) lesions and primary effusion lymphomas (pels), suggesting a pathogenetic role for this virus in these lesions. however, kshv has also been identified in a v
The biology of Kaposi’s sarcoma-associated herpesvirus and the infection of human immunodeficiency virus
✍ Scribed by Di Qin; Chun Lu
- Publisher
- SP Wuhan Institute of Virology, CAS
- Year
- 2008
- Tongue
- English
- Weight
- 241 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1674-0769
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Kaposi's sarcoma‐associated herpesvirus (KSHV) is related causally to Kaposi's sarcoma, primary effusion lymphoma, and a subset of cases of multicentric Castleman's disease. As the numbers of acquired immunodeficiency syndrome (AIDS) patients have increased, KSHV‐associated diseases hav
## Abstract We report the molecular characterization of 38 new Kaposi's sarcoma‐associated herpesvirus (KSHV) strains from Russian patients with either classic (25 cases), epidemic/AIDS‐associated (7 cases), or posttransplant/immunosuppressed patients (6 cases), or Kaposi's sarcoma (KS). While a co
## Abstract ## BACKGROUND Kaposi sarcoma (KS) is an angioproliferative disease that may represent a difficult therapeutic challenge in disseminated stages. The efficacy of taxanes (paclitaxel and docetaxel), as agents with antiangiogenic properties, has been described previously in the treatment o